Journal Article

VII.1 Assessment of cardiovascular risk factors

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 17, issue suppl_7, pages 88-88
Published in print July 2002 | ISSN: 0931-0509
Published online July 2002 | e-ISSN: 1460-2385 | DOI: http://dx.doi.org/10.1093/ndt/17.suppl_7.88
VII.1 Assessment of cardiovascular risk factors

Show Summary Details

Preview

All patients on haemodialysis should be considered to be at the greatest risk of developing vascular disease. Measures to prevent vascular disease should not be based on the presence or absence of prior vascular disease or other risk factors, but should rather assume that the risk for vascular disease is already sufficient enough to warrant the most aggressive management.

Guideline VII.1

A. Patients’ cardiovascular risk should be formally assessed and documented at the onset of haemodialysis and 6 monthly thereafter. Risk assessment includes modifiable risk factors such as cigarette smoking, hyperglycaemia, dyslipidaemia, and hypertension.

(Evidence level: B)

Journal Article.  0 words. 

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.